@ARTICLE{
author={Fung Scott,...,Fabri Milotka J,...,Pelemis Mijomir R,...,(broj koautora 22)},
year={2017},
title={Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study},
journal={JOURNAL OF HEPATOLOGY},
volume={66},
number={1},
pages={11-18},
document_type={Article},
} 

@ARTICLE{
author={Fung Scott,...,Fabri Milotka J,...,Pelemis Mijomir R,...,(broj koautora 15)},
year={2015},
title={Long Term Efficacy and Safety of Tenofovir DF (TDF) in Chronic Hepatitis B Patients (CHB) with Documented Lamivudine Resistance (LAM-R): 5 Year Results From a Randomized, Controlled Trial},
journal={HEPATOLOGY},
volume={62},
number={},
pages={1184A-1185A},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Fung Scott,...,Fabri Milotka J,...,Pelemis Mijomir R,...,(broj koautora 16)},
year={2014},
title={Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B},
journal={GASTROENTEROLOGY},
volume={146},
number={4},
pages={980-U521},
document_type={Article},
}